Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
Cancer diagnosis risk for women with sleep apnoea
Tues May 21st - Women with obstructive sleep apnoea are more likely to be diagnosed with cancer than men with the condition, according to Greek research published last night. More
Technique uncovers signs of potentially fatal cardiac arrest
Tues May 21st - A brain imaging technique has been used for the first time to help identify the signs of hypertrophic cardiomyopathy, a UK study revealed last night. More
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote: on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...
On 12/03/2017 Steph wrote:
The photo you have paired with this article is its... on 'Fat shaming' limits...

Smartphone app helps TB patients

Monday February 25th, 2019

Patients with tuberculosis are more likely to continue their drug treatment if they are supported by treatment via smartphones, according to a new study.

Researchers at University College London, UK, analysed 226 patients in London, 58% of whom had a history of homelessness, mental health issues, imprisonment or addiction.

The findings, published in The Lancet, show that seven out of 10 patients completed at least 80% of their scheduled treatments when using an app on their smartphone, which proved they had taken their treatment.

Patients used the app to film themselves taking the treatment, which was submitted securely to the clinical team. For patients who had directly observed treatment at face-to-face appointments, fewer than half of treatment doses could be confirmed.

Lead author Professor Andrew Hayward, of UCL Epidemiology and Heath Care, said: “Taking regular tuberculosis treatment is difficult, but if poorly treated, the disease can kill, infect others and become resistant to antibiotics.

“National TB authorities worldwide often require patients to meet health care workers daily to take their medications under direct observation, a standard of care that is often difficult to maintain over the many months that TB treatment lasts.

“Our NIHR funded trial shows patients can use a smartphone app to prove they have taken their treatment and this is much more effective, cheaper and convenient than face-to-face meetings.

“This allowed us to support tuberculosis treatment even in people who are homeless or suffering from drug addiction. We are very excited about the potential of this technology to improve treatment of this killer disease.”

Dr Tereza Kasaeva, director of the World Health Organisation’s global TB programme, described the results as an “important landmark”.

“This innovative approach is fully aligned with WHO's strategic vision to provide patient-centred care, increase adherence and improve treatment outcomes for the people with TB,” she added.

Lancet 22 February 2019

Tags: Respiratory | UK News

Printer friendly page Printer friendly page

Comment on this article:

<a>,<b> & <p> tags allowed
Please enter the letters displayed:
(not case sensitive)